GlaxoSmithKline PLC (NYSE:GSK)

Delayed Data
As of Sep 20
 +0.31 / +0.75%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 41.98, with a high estimate of 53.59 and a low estimate of 35.26. The median estimate represents a +0.84% increase from the last price of 41.63.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.94%
Growthannually -8.01%


Growthquarterly 8.08%
Growthannually 0.79%
Key to the earnings and sales forecast charts.